can cord blood fix cf? we didnt bank our dd's but i was thinking about it today and was wondering if we had, could it have helped her? could a future sibling's cord help her? or does it not work that way? i really dont know much about cord blood (or cf for that matter, im still pretty new at all the gene side of it)
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an alternative browser.
You should upgrade or use an alternative browser.
cord blood
- Thread starter fuel1316
- Start date
can cord blood fix cf? we didnt bank our dd's but i was thinking about it today and was wondering if we had, could it have helped her? could a future sibling's cord help her? or does it not work that way? i really dont know much about cord blood (or cf for that matter, im still pretty new at all the gene side of it)
can cord blood fix cf? we didnt bank our dd's but i was thinking about it today and was wondering if we had, could it have helped her? could a future sibling's cord help her? or does it not work that way? i really dont know much about cord blood (or cf for that matter, im still pretty new at all the gene side of it)
can cord blood fix cf? we didnt bank our dd's but i was thinking about it today and was wondering if we had, could it have helped her? could a future sibling's cord help her? or does it not work that way? i really dont know much about cord blood (or cf for that matter, im still pretty new at all the gene side of it)
can cord blood fix cf? we didnt bank our dd's but i was thinking about it today and was wondering if we had, could it have helped her? could a future sibling's cord help her? or does it not work that way? i really dont know much about cord blood (or cf for that matter, im still pretty new at all the gene side of it)
At present, cord blood stem cells are known to differentiate into neural cells which lends promise for such diseases as Alzheimer's and Parkinson's IN ADDITION to treating hematological and immune disorders. CF is not an immune disorder, but perhaps future studies will show promise for CF. Below is an email update from CBR (we have "banked" both of our children's cord blood) - what is stated is quite interesting regarding the dangers of using embryonic stem cells.
Dear Families of Cord Blood Registry,
Stem cells were a focus of news headlines once again last week, following President Obama's Executive Order lifting the federal funding ban on embryonic research. Yet in all of the debate and discussion, it's sometimes difficult to sort through what's relevant and accurate from what's not.
In our ongoing effort to offer you perspectives and commentary about stem cell news and developments, we are pleased to introduce you to our new blog, The Stem Cell Source.
Our first post titled Not All Stem Cells Are the Same, calls attention to an article written for U.S. News & World Report by former director of the National Institutes of Health (NIH), Dr. Bernadine Healy. Dr. Healy points out that research with non-embryonic stem cells "has scored major wins;" however, recent data shows that embryonic stem cells injected into patients can cause disabling if not deadly tumors.
Here's the irony with the President's announcement: now that embryonic researchers have the potential to receive federal funding, embryonic stem cells may not be the primary focus of stem cell research moving forward.
Researchers are using a child's own newborn stem cells, collected at birth from cord blood, to advance treatments for conditions that have no cure today. As the global leader in the collection and preservation of newborn stem cells, Cord Blood Registry is playing a crucial role in facilitating this type of medical research.
We invite you to join our discussion, spread the word, and learn more by signing up
to receive updates from our blog, The Stem Cell Source.
Sincerely,
David Zitlow
Senior Vice President, Public Affairs
Dear Families of Cord Blood Registry,
Stem cells were a focus of news headlines once again last week, following President Obama's Executive Order lifting the federal funding ban on embryonic research. Yet in all of the debate and discussion, it's sometimes difficult to sort through what's relevant and accurate from what's not.
In our ongoing effort to offer you perspectives and commentary about stem cell news and developments, we are pleased to introduce you to our new blog, The Stem Cell Source.
Our first post titled Not All Stem Cells Are the Same, calls attention to an article written for U.S. News & World Report by former director of the National Institutes of Health (NIH), Dr. Bernadine Healy. Dr. Healy points out that research with non-embryonic stem cells "has scored major wins;" however, recent data shows that embryonic stem cells injected into patients can cause disabling if not deadly tumors.
Here's the irony with the President's announcement: now that embryonic researchers have the potential to receive federal funding, embryonic stem cells may not be the primary focus of stem cell research moving forward.
Researchers are using a child's own newborn stem cells, collected at birth from cord blood, to advance treatments for conditions that have no cure today. As the global leader in the collection and preservation of newborn stem cells, Cord Blood Registry is playing a crucial role in facilitating this type of medical research.
We invite you to join our discussion, spread the word, and learn more by signing up
to receive updates from our blog, The Stem Cell Source.
Sincerely,
David Zitlow
Senior Vice President, Public Affairs
At present, cord blood stem cells are known to differentiate into neural cells which lends promise for such diseases as Alzheimer's and Parkinson's IN ADDITION to treating hematological and immune disorders. CF is not an immune disorder, but perhaps future studies will show promise for CF. Below is an email update from CBR (we have "banked" both of our children's cord blood) - what is stated is quite interesting regarding the dangers of using embryonic stem cells.
Dear Families of Cord Blood Registry,
Stem cells were a focus of news headlines once again last week, following President Obama's Executive Order lifting the federal funding ban on embryonic research. Yet in all of the debate and discussion, it's sometimes difficult to sort through what's relevant and accurate from what's not.
In our ongoing effort to offer you perspectives and commentary about stem cell news and developments, we are pleased to introduce you to our new blog, The Stem Cell Source.
Our first post titled Not All Stem Cells Are the Same, calls attention to an article written for U.S. News & World Report by former director of the National Institutes of Health (NIH), Dr. Bernadine Healy. Dr. Healy points out that research with non-embryonic stem cells "has scored major wins;" however, recent data shows that embryonic stem cells injected into patients can cause disabling if not deadly tumors.
Here's the irony with the President's announcement: now that embryonic researchers have the potential to receive federal funding, embryonic stem cells may not be the primary focus of stem cell research moving forward.
Researchers are using a child's own newborn stem cells, collected at birth from cord blood, to advance treatments for conditions that have no cure today. As the global leader in the collection and preservation of newborn stem cells, Cord Blood Registry is playing a crucial role in facilitating this type of medical research.
We invite you to join our discussion, spread the word, and learn more by signing up
to receive updates from our blog, The Stem Cell Source.
Sincerely,
David Zitlow
Senior Vice President, Public Affairs
Dear Families of Cord Blood Registry,
Stem cells were a focus of news headlines once again last week, following President Obama's Executive Order lifting the federal funding ban on embryonic research. Yet in all of the debate and discussion, it's sometimes difficult to sort through what's relevant and accurate from what's not.
In our ongoing effort to offer you perspectives and commentary about stem cell news and developments, we are pleased to introduce you to our new blog, The Stem Cell Source.
Our first post titled Not All Stem Cells Are the Same, calls attention to an article written for U.S. News & World Report by former director of the National Institutes of Health (NIH), Dr. Bernadine Healy. Dr. Healy points out that research with non-embryonic stem cells "has scored major wins;" however, recent data shows that embryonic stem cells injected into patients can cause disabling if not deadly tumors.
Here's the irony with the President's announcement: now that embryonic researchers have the potential to receive federal funding, embryonic stem cells may not be the primary focus of stem cell research moving forward.
Researchers are using a child's own newborn stem cells, collected at birth from cord blood, to advance treatments for conditions that have no cure today. As the global leader in the collection and preservation of newborn stem cells, Cord Blood Registry is playing a crucial role in facilitating this type of medical research.
We invite you to join our discussion, spread the word, and learn more by signing up
to receive updates from our blog, The Stem Cell Source.
Sincerely,
David Zitlow
Senior Vice President, Public Affairs
At present, cord blood stem cells are known to differentiate into neural cells which lends promise for such diseases as Alzheimer's and Parkinson's IN ADDITION to treating hematological and immune disorders. CF is not an immune disorder, but perhaps future studies will show promise for CF. Below is an email update from CBR (we have "banked" both of our children's cord blood) - what is stated is quite interesting regarding the dangers of using embryonic stem cells.
Dear Families of Cord Blood Registry,
Stem cells were a focus of news headlines once again last week, following President Obama's Executive Order lifting the federal funding ban on embryonic research. Yet in all of the debate and discussion, it's sometimes difficult to sort through what's relevant and accurate from what's not.
In our ongoing effort to offer you perspectives and commentary about stem cell news and developments, we are pleased to introduce you to our new blog, The Stem Cell Source.
Our first post titled Not All Stem Cells Are the Same, calls attention to an article written for U.S. News & World Report by former director of the National Institutes of Health (NIH), Dr. Bernadine Healy. Dr. Healy points out that research with non-embryonic stem cells "has scored major wins;" however, recent data shows that embryonic stem cells injected into patients can cause disabling if not deadly tumors.
Here's the irony with the President's announcement: now that embryonic researchers have the potential to receive federal funding, embryonic stem cells may not be the primary focus of stem cell research moving forward.
Researchers are using a child's own newborn stem cells, collected at birth from cord blood, to advance treatments for conditions that have no cure today. As the global leader in the collection and preservation of newborn stem cells, Cord Blood Registry is playing a crucial role in facilitating this type of medical research.
We invite you to join our discussion, spread the word, and learn more by signing up
to receive updates from our blog, The Stem Cell Source.
Sincerely,
David Zitlow
Senior Vice President, Public Affairs
Dear Families of Cord Blood Registry,
Stem cells were a focus of news headlines once again last week, following President Obama's Executive Order lifting the federal funding ban on embryonic research. Yet in all of the debate and discussion, it's sometimes difficult to sort through what's relevant and accurate from what's not.
In our ongoing effort to offer you perspectives and commentary about stem cell news and developments, we are pleased to introduce you to our new blog, The Stem Cell Source.
Our first post titled Not All Stem Cells Are the Same, calls attention to an article written for U.S. News & World Report by former director of the National Institutes of Health (NIH), Dr. Bernadine Healy. Dr. Healy points out that research with non-embryonic stem cells "has scored major wins;" however, recent data shows that embryonic stem cells injected into patients can cause disabling if not deadly tumors.
Here's the irony with the President's announcement: now that embryonic researchers have the potential to receive federal funding, embryonic stem cells may not be the primary focus of stem cell research moving forward.
Researchers are using a child's own newborn stem cells, collected at birth from cord blood, to advance treatments for conditions that have no cure today. As the global leader in the collection and preservation of newborn stem cells, Cord Blood Registry is playing a crucial role in facilitating this type of medical research.
We invite you to join our discussion, spread the word, and learn more by signing up
to receive updates from our blog, The Stem Cell Source.
Sincerely,
David Zitlow
Senior Vice President, Public Affairs
At present, cord blood stem cells are known to differentiate into neural cells which lends promise for such diseases as Alzheimer's and Parkinson's IN ADDITION to treating hematological and immune disorders. CF is not an immune disorder, but perhaps future studies will show promise for CF. Below is an email update from CBR (we have "banked" both of our children's cord blood) - what is stated is quite interesting regarding the dangers of using embryonic stem cells.
Dear Families of Cord Blood Registry,
Stem cells were a focus of news headlines once again last week, following President Obama's Executive Order lifting the federal funding ban on embryonic research. Yet in all of the debate and discussion, it's sometimes difficult to sort through what's relevant and accurate from what's not.
In our ongoing effort to offer you perspectives and commentary about stem cell news and developments, we are pleased to introduce you to our new blog, The Stem Cell Source.
Our first post titled Not All Stem Cells Are the Same, calls attention to an article written for U.S. News & World Report by former director of the National Institutes of Health (NIH), Dr. Bernadine Healy. Dr. Healy points out that research with non-embryonic stem cells "has scored major wins;" however, recent data shows that embryonic stem cells injected into patients can cause disabling if not deadly tumors.
Here's the irony with the President's announcement: now that embryonic researchers have the potential to receive federal funding, embryonic stem cells may not be the primary focus of stem cell research moving forward.
Researchers are using a child's own newborn stem cells, collected at birth from cord blood, to advance treatments for conditions that have no cure today. As the global leader in the collection and preservation of newborn stem cells, Cord Blood Registry is playing a crucial role in facilitating this type of medical research.
We invite you to join our discussion, spread the word, and learn more by signing up
to receive updates from our blog, The Stem Cell Source.
Sincerely,
David Zitlow
Senior Vice President, Public Affairs
Dear Families of Cord Blood Registry,
Stem cells were a focus of news headlines once again last week, following President Obama's Executive Order lifting the federal funding ban on embryonic research. Yet in all of the debate and discussion, it's sometimes difficult to sort through what's relevant and accurate from what's not.
In our ongoing effort to offer you perspectives and commentary about stem cell news and developments, we are pleased to introduce you to our new blog, The Stem Cell Source.
Our first post titled Not All Stem Cells Are the Same, calls attention to an article written for U.S. News & World Report by former director of the National Institutes of Health (NIH), Dr. Bernadine Healy. Dr. Healy points out that research with non-embryonic stem cells "has scored major wins;" however, recent data shows that embryonic stem cells injected into patients can cause disabling if not deadly tumors.
Here's the irony with the President's announcement: now that embryonic researchers have the potential to receive federal funding, embryonic stem cells may not be the primary focus of stem cell research moving forward.
Researchers are using a child's own newborn stem cells, collected at birth from cord blood, to advance treatments for conditions that have no cure today. As the global leader in the collection and preservation of newborn stem cells, Cord Blood Registry is playing a crucial role in facilitating this type of medical research.
We invite you to join our discussion, spread the word, and learn more by signing up
to receive updates from our blog, The Stem Cell Source.
Sincerely,
David Zitlow
Senior Vice President, Public Affairs
At present, cord blood stem cells are known to differentiate into neural cells which lends promise for such diseases as Alzheimer's and Parkinson's IN ADDITION to treating hematological and immune disorders. CF is not an immune disorder, but perhaps future studies will show promise for CF. Below is an email update from CBR (we have "banked" both of our children's cord blood) - what is stated is quite interesting regarding the dangers of using embryonic stem cells.
<br />
<br />Dear Families of Cord Blood Registry,
<br />
<br />Stem cells were a focus of news headlines once again last week, following President Obama's Executive Order lifting the federal funding ban on embryonic research. Yet in all of the debate and discussion, it's sometimes difficult to sort through what's relevant and accurate from what's not.
<br />
<br />In our ongoing effort to offer you perspectives and commentary about stem cell news and developments, we are pleased to introduce you to our new blog, The Stem Cell Source.
<br />
<br />Our first post titled Not All Stem Cells Are the Same, calls attention to an article written for U.S. News & World Report by former director of the National Institutes of Health (NIH), Dr. Bernadine Healy. Dr. Healy points out that research with non-embryonic stem cells "has scored major wins;" however, recent data shows that embryonic stem cells injected into patients can cause disabling if not deadly tumors.
<br />
<br />Here's the irony with the President's announcement: now that embryonic researchers have the potential to receive federal funding, embryonic stem cells may not be the primary focus of stem cell research moving forward.
<br />Researchers are using a child's own newborn stem cells, collected at birth from cord blood, to advance treatments for conditions that have no cure today. As the global leader in the collection and preservation of newborn stem cells, Cord Blood Registry is playing a crucial role in facilitating this type of medical research.
<br />We invite you to join our discussion, spread the word, and learn more by signing up
<br />to receive updates from our blog, The Stem Cell Source.
<br />Sincerely,
<br />David Zitlow
<br />Senior Vice President, Public Affairs
<br />
<br />Dear Families of Cord Blood Registry,
<br />
<br />Stem cells were a focus of news headlines once again last week, following President Obama's Executive Order lifting the federal funding ban on embryonic research. Yet in all of the debate and discussion, it's sometimes difficult to sort through what's relevant and accurate from what's not.
<br />
<br />In our ongoing effort to offer you perspectives and commentary about stem cell news and developments, we are pleased to introduce you to our new blog, The Stem Cell Source.
<br />
<br />Our first post titled Not All Stem Cells Are the Same, calls attention to an article written for U.S. News & World Report by former director of the National Institutes of Health (NIH), Dr. Bernadine Healy. Dr. Healy points out that research with non-embryonic stem cells "has scored major wins;" however, recent data shows that embryonic stem cells injected into patients can cause disabling if not deadly tumors.
<br />
<br />Here's the irony with the President's announcement: now that embryonic researchers have the potential to receive federal funding, embryonic stem cells may not be the primary focus of stem cell research moving forward.
<br />Researchers are using a child's own newborn stem cells, collected at birth from cord blood, to advance treatments for conditions that have no cure today. As the global leader in the collection and preservation of newborn stem cells, Cord Blood Registry is playing a crucial role in facilitating this type of medical research.
<br />We invite you to join our discussion, spread the word, and learn more by signing up
<br />to receive updates from our blog, The Stem Cell Source.
<br />Sincerely,
<br />David Zitlow
<br />Senior Vice President, Public Affairs